Feasibility and Safety of a Novel 4 Fr Sheath Transradial and Transbrachial Approach for Mechanical Thrombectomy in Selected Patients

新型4Fr鞘管经桡动脉和经肱动脉入路行机械血栓切除术在特定患者中的可行性和安全性

阅读:1

Abstract

The transradial/transbrachial approach for mechanical thrombectomy offers potential reductions in access-site complications, but the feasibility of downsizing to a 4 Fr guiding sheath remains to be systematically assessed. To evaluate the feasibility and safety of mechanical thrombectomy performed through a 4 Fr transradial/transbrachial approach in selected patients and to compare procedural metrics with those of a contemporaneous transfemoral approach cohort treated at the same center, we retrospectively reviewed consecutive patients who underwent mechanical thrombectomy between December 2023 and December 2024. Overall, 17 patients were treated with a 4 Fr sheath through the right transradial/transbrachial approach and 87 with transfemoral approach. Baseline demographics, procedural times, recanalization rates, and access-site complications were compared using the Mann-Whitney U or χ(2) tests, as appropriate. Successful recanalization (modified Thrombolysis in Cerebral Infarction grade ≥ 2b) was achieved in 14 of 17 cases (82%) in the 4 Fr group, comparable to 78 of 87 cases (90%) in the transfemoral approach group (p = 0.39). Median puncture-to-recanalization time was 34 min (interquartile range 27.8-67) versus 36 min (interquartile range 23-56.5) (p = 0.78). No symptomatic intracranial hemorrhage occurred in the 4 Fr cohort. Access-site complications were limited to 1 minor superficial hematoma (6%), whereas the transfemoral approach group experienced 3 access-site events (3.4%), all pseudoaneurysms. A 4 Fr transradial/transbrachial approach for mechanical thrombectomy is feasible and indicates a favorable safety profile without prolonging procedure time in carefully selected right-sided or posterior circulation lesions with low thrombus burden. Larger prospective studies are warranted to confirm these signals and to explore applicability to broader patient populations.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。